Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology
recent articles
Jason An-Chi-Sung, CEO of Urban Datalab, and Tamas Regenyi, CCO of Aiforia Technologies signed a partnership agreement to make AI solutions in digital pathology accessible to hospitals in South Korea. Aiforia Technologies Plc, Press Release,...
Jakarta, Indonesia and Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Siloam Hospitals Group, Indonesia’s leading private healthcare provider, have signed a Memorandum of...
MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with...
Utilizing Owkin’s expansive data network and cutting-edge AI, this solution optimizes pre-screening for gBRCA mutations in breast cancer directly from digitized H&E pathology slides The solution aims to improve gBRCA...
Proscia: Life sciences organizations can rapidly build AI algorithms to discover biomarkers, optimize clinical trials, and advance companion diagnostics—powered by the first digital pathology platform to seamlessly integrate foundation...
Mindpeak: Funding strengthens the product development roadmap for AI-powered histopathological assessments, supporting clinical labs and biopharma companies worldwide. HAMBURG, Germany--(BUSINESS WIRE)--Mindpeak, the leader in AI-powered...
